// App-Quantinova.ai

: A Comparison of Normal Lung Anatomy to Minimal to Established Fibrosis in Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • F. Xu

Principal Investigators

  • N. Tanabe

  • J. E. McDonough

  • D. M. Vasilescu

  • K. Ikezoe

  • D. Kinose

  • K. Ng

  • S. Verleden

  • B. Vanaudenaerde

  • J. Verschakelen

  • J. D. Cooper

  • M. E. Lenburg

  • A. Spira

  • R. Ng

  • J. C. Hogg

Medical Centers

  • Pathology and Laboratory Medicine, University of BC, Vancouver, BC, Canada

  • Department of Respiratory Medicine, Kumamoto University, Kumamoto, Japan.

  • Pneumology, KU Leuven, Leuven, BC, Canada,

  • Centre for Heart Lung Innovation,Medicine, Vancouver BC, Canada

  • Centre for Heart and Lung Innovation, UBC, VANCOUVER, BC, Canada,

  • Kyoto University, Kyoto, Japan

  • The Francis Crick Institute, London, United Kingdom

  • Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium

  • Leuven Lung Transplant Unit, KU Leuven and UZ Gasthuisberg, Leuven, Belgium,

  • Univ of Pennsylvania Medical Ctr, Philadelphia, PA, United States,

  • Boston University School of Medicine, Boston, MA, United States

  • Boston University Medical Campus, Boston, MA, United States,

  • UBC, VANCOUVER, BC, Canada

  • The Center for Heart and Lung Innovation, St Pauls Hospital, Vancouver, BC, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • Nuclear factor kappa-light-chain-enhancer of activated B cells

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved